^
11ms
B010-A Injection for Treating Patients With GPC3 Positive Advanced Hepatocellular Carcinoma (clinicaltrials.gov)
P1, N=3, Active, not recruiting, Tongji University | Recruiting --> Active, not recruiting | Trial completion date: Sep 2022 --> Sep 2024 | Trial primary completion date: Aug 2022 --> Aug 2024
Enrollment closed • Trial completion date • Trial primary completion date • Metastases
|
GPC3 (Glypican 3)
|
GPC3 positive
|
B010-A
over2years
B010-A Injection for Treating Patients With GPC3 Positive Advanced Hepatocellular Carcinoma (clinicaltrials.gov)
P1, N=3, Recruiting, Tongji University | Trial primary completion date: May 2022 --> Aug 2022
Trial primary completion date
|
GPC3 (Glypican 3) • CRP (C-reactive protein)
|
GPC3 positive
|
B010-A
almost3years
B010-A Injection for Treating Patients With GPC3 Positive Advanced Hepatocellular Carcinoma (clinicaltrials.gov)
P1, N=3, Recruiting, Tongji University | Initiation date: Jul 2021 --> Oct 2021
Trial initiation date
|
GPC3 (Glypican 3) • CRP (C-reactive protein)
|
GPC3 positive
|
B010-A
3years
Clinical • New P1 trial
|
GPC3 (Glypican 3) • CRP (C-reactive protein)
|
GPC3 positive
|
B010-A